PUBLISHER: The Business Research Company | PRODUCT CODE: 1826843
PUBLISHER: The Business Research Company | PRODUCT CODE: 1826843
Varicose vein treatment involves medical procedures and interventions aimed at relieving symptoms, improving blood circulation, and preventing complications associated with swollen, twisted veins, primarily in the legs. It also addresses cosmetic concerns by improving the appearance of the affected veins while minimizing the risk of issues such as pain, ulcers, or blood clots.
The primary products used in varicose vein treatment include ablation devices, radiofrequency ablation devices, and laser ablation devices. Ablation devices are medical tools that remove or destroy abnormal tissue, such as tumors or varicose veins, through techniques such as heat, cold, or electrical energy. Common procedures include injection sclerotherapy, endovenous ablation, and surgical ligation or stripping. These treatments are typically provided by hospitals, specialized clinics, ambulatory surgical centers, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The varicose veins treatment market research report is one of a series of new reports from The Business Research Company that provides varicose veins treatment market statistics, including varicose veins treatment industry global market size, regional shares, competitors with a varicose veins treatment market share, detailed varicose veins treatment market segments, market trends and opportunities, and any further data you may need to thrive in the varicose veins treatment industry. This varicose veins treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The varicose veins treatment market size has grown strongly in recent years. It will grow from $1.99 billion in 2024 to $2.11 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to a rise in sedentary lifestyles, rise in outpatient treatments, rise in cosmetic concerns related to varicose veins, increasing in preventative treatments for varicose veins, and increasing adoption of lasers.
The varicose veins treatment market size is expected to see strong growth in the next few years. It will grow to $2.69 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising preference for minimally invasive surgeries, increasing obesity rates, expanding healthcare infrastructure, rising disposable incomes, and increased government spending on healthcare. Major trends in the forecast period include technological advancements, integration of AI, 3D imaging, advanced compression therapy, and combination therapies.
The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of endovenous laser ablation devices and sclerotherapy foams sourced from Switzerland and Brazil, exacerbating out-of-pocket costs and delaying minimally invasive procedures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing demand for minimally invasive procedures is expected to drive the expansion of the varicose veins treatment market. Minimally invasive procedures involve the use of small incisions and specialized instruments to perform surgeries with less tissue damage, leading to less pain, quicker recovery, and minimal scarring compared to traditional open surgery. The demand for these procedures is fueled by factors such as reduced recovery times, better patient outcomes, and the aging population, which together contribute to improved patient safety, satisfaction, and healthcare efficiency. Minimally invasive treatments for varicose veins, such as endovenous laser therapy (EVLT) or sclerotherapy, offer effective solutions with minimal discomfort, faster recovery, and fewer complications. For example, The Aesthetic Society, a US-based organization, reported in August 2023 that Americans spent over $11.8 billion on aesthetic procedures in 2022, a 2% increase from the previous year. This rising preference for minimally invasive procedures is driving the growth of the varicose veins treatment market.
Companies in the varicose veins treatment market are concentrating on developing innovative solutions, such as anesthesia-free treatments, to improve patient outcomes, simplify treatment monitoring, enhance access to care, and offer personalized therapeutic approaches. Anesthesia-free treatment involves conducting medical procedures without anesthesia, ensuring safer operations, quicker recovery, and better patient comfort. For instance, in April 2024, VVT MEDICAL Ltd., an Israel-based medical device company, received approval from South Korea's Ministry of Food and Drug Safety for its ScleroSafe platform, an advanced solution for minimally invasive varicose vein treatment. This platform uses a nonthermal, nontumescent (NT-NT) method, eliminating the need for heat or tumescent anesthesia, thus providing a painless, anesthesia-free procedure. Intended for both medical and aesthetic uses, the platform focuses on patient comfort and effectiveness. It has also received several regulatory approvals, including CE Mark certification and FDA 510(k) clearance, while adhering to Good Manufacturing Practices (GMP), making ScleroSafe a groundbreaking innovation in varicose vein management.
In January 2024, VVT MEDICAL Ltd. teamed up with Methapharm Inc., a Canadian pharmaceutical company specializing in varicose vein treatment, to introduce a dual syringe technique for varicose vein treatment. This partnership enables VVT Medical to strengthen its position in the U.S. market by leveraging Methapharm's expertise in promoting and distributing the ScleroSafe platform.
Major players in the varicose veins treatment market are Medtronic PLC, Becton Dickinson and Company, Boston Scientific Corporation, BTG Limited, Acibadem International Group, Froedtert Health Incorporated, Merit Medical Systems Incorporated, uvahealth, AngioDynamics Incorporated, Medi USA Limited Partnership, Dornier MedTech GmbH, Sciton Incorporated, Invera Medical Limited, Biolitec AG, Alma Lasers Limited, Won Tech Company Limited, F Care Systems S.A., Eufoton S.R.L., Vascular Solutions Incorporated, Theraclion S.A., uGlow Med Spa, and Varicose Veins India.
North America was the largest region in the varicose veins treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in varicose veins treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the varicose veins treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The varicose veins treatment market consists of revenues earned by entities providing services such as diagnostic services, minimally invasive treatments, and surgical services. The market value includes the value of related goods sold by the service provider or included within the service offering. The varicose veins treatment market also includes sales of laser treatment devices, sclerotherapy agents, and radiofrequency ablation devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Varicose Veins Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on varicose veins treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for varicose veins treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The varicose veins treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.